La Jolla-based nonprofit California Institute for Biomedical Research has received an award from the Wellcome Trust, a British charitable foundation, for an undisclosed amount of money. The grant will help the institute develop a therapy to treat a hormone-based form of prostate cancer.
The award will fully support Calibr’s efforts to advance its therapy into investigational new drug status, which includes evaluating its pre-clinical efficacy, setting the stage for an industry-partnered phase 1 clinical trial.
Calibr, founded in 2012 with aims to accelerate translating basic biomedical research into medications, employs more than 80 scientists in its La Jolla headquarters.